Skip to content
BALCAO · PHARMACEUTICAL PREPARATIONS · SMALL CAP

BetterLife Pharma Inc. BETRF

11 fiscal years on record · USD · FY2018 reported · SEC filings only
CAD -9.1M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

·
Revenue, FY2018 · full 11-year series below
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
ROE

No chart to show — the reason differs by year; see each year in the table below.

Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot available: we don't have total assets or current liabilities for this period.

Cash & shareholders

·
returned in FY2018 · dividends + net buybacks

Total assetsCAD 8.6M
EquityCAD 3.5M
CashCAD 74,800.00

Equity funds 41% of total assets.

The 11-year record

11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
BETRF, 11-year financial record
Metric 20182017201620152014201320122011201020092008
Revenue $B◌◌◌◌◌◌◌◌◌◌◌
Operating income $B◌◌−0.0−0.0−0.0◌◌◌◌◌◌
EBITDA $B◌◌◌−0.0−0.0◌◌◌◌◌◌
Income tax $B◌◌◌◌◌◌◌◌◌◌◌
Net income CAD B−0.0−0.0◌◌◌−0.00.00.0−0.0−0.0−0.0
EPS, diluted CAD −0.100.00◌◌◌−0.20◌◌◌◌◌
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————————
ROE %—————————◌◌
Shares out B0.100.080.080.070.070.100.04◌◌◌◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 11 failures in 34 reconciliationsAUDITED

Reconciled in 1 of the 11 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Six checks were skipped: EPS is not tagged before 2013.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency11 failures
ActivityPharmaceutical Preparations
Listed onOTC market
Incorporated inoutside the United States — SEC code A1
Fiscal year endsJanuary 31
Data on record since2008

Share this section

Download image